Karla Resendiz
Overview
Explore the profile of Karla Resendiz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
47
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Weber M, Himebauch A, Zuckerberg J, Resendiz K, Conlon T
Pediatr Crit Care Med
. 2024 Nov;
25(11):e447-e448.
PMID: 39495712
No abstract available.
2.
Weber M, Woods-Hill C, Resendiz K, Nelson E, Ryan M, Brennan L, et al.
Pediatr Crit Care Med
. 2024 May;
25(5):e232-e238.
PMID: 38695702
Objectives: Ethanol lock therapy (ELT) is a potential method of central catheter salvage following central line-associated bloodstream infection (CLABSI) although there is potential risk of catheter damage in polyurethane catheters....
3.
Jacobwitz M, Mulvihill C, Kaufman M, Gonzalez A, Resendiz K, Francoeur C, et al.
Neurocrit Care
. 2023 Oct;
40(3):984-995.
PMID: 37783824
Background: Pediatric refractory status epilepticus (RSE) often requires management with anesthetic infusions, but few data compare first-line anesthetics. This study aimed to compare the efficacy and adverse effects of midazolam...
4.
Jacobwitz M, Mulvihill C, Kaufman M, Gonzalez A, Resendiz K, MacDonald J, et al.
Neurology
. 2022 Jul;
99(12):e1227-e1238.
PMID: 35817569
Background And Objectives: Few data are available regarding the use of anesthetic infusions for refractory status epilepticus (RSE) in children and neonates, and ketamine use is increasing despite limited data....
5.
ONeil E, Schmees L, Resendiz K, Justino H, Anders M
Crit Care Explor
. 2020 Mar;
2(1):e0075.
PMID: 32166295
Objectives: To describe the use of inhaled or endotracheally instilled tranexamic acid in critically ill pediatric patients for the treatment of pulmonary hemorrhage, which can be severe, life-threatening, and include...
6.
Moffett B, Resendiz K, Morris J, Akcan-Arikan A, Checchia P
J Pediatr Pharmacol Ther
. 2019 Apr;
24(2):107-116.
PMID: 31019403
Objective: Vancomycin is often used in the pediatric cardiac surgical population, but few pharmacokinetic data are available to guide dosing. Methods: A retrospective, population pharmacokinetic study was performed for patients...
7.
Brown C, Pena A, Resendiz K
J Am Pharm Assoc (2003)
. 2011 Sep;
51(5):619-22.
PMID: 21896460
Objectives: To determine how often pharmacists inquire about patients' complementary and alternative medicine (CAM) use, actions taken in response to patients' CAM use, and demographic or professional characteristics that predict...